Follow-up testing for individuals with unexplained developmental delay or intellectual disability, autism spectrum disorders, or congenital anomalies with a previously normal conventional chromosome study.

CMA is recommended for individuals thought to have a medical condition associated with a chromosomal deletion or duplication. A missing or extra piece of chromosomal material can arise …

This test compares the patient’s sample to a normal control sample to find very small missing or extra chromosome pieces that cannot be seen under a microscope.

This array is designed to identify numeric chromosomal abnormalities, unbalanced structural rearrangements, and copy number changes genome-wide in regions of known clinical significance …

Call 800-345-4363 to request forms, or photocopy the Clinical Questionnaire for SNP Microarray. This test also may be performed on adults.

Chromosomal microarray (CMA) is increasingly utilized for genetic testing of individuals with unexplained developmental delay/intellectual disability (DD/ID), autism spectrum disorders (ASD), or …

Chromosomal Microarray Analysis provides comprehensive genetic testing for the most common chromosomal conditions as well as a large number of severe genetic conditions not detected by …

Based on current published guidelines, exome or genome sequencing can now be considered as first-tier tests for patients with unexplained epilepsy, developmental delay, intellectual disabilities and/or …

Chromosomal microarray (CMA) is a high-resolution method for detecting copy number changes (gains or losses) across the entire genome in a single assay and is sometimes called a molecular karyotype.

Dec 20, 2023 · Chromosomal Microarray Analysis (CMA) is a genetic test that looks for changes in chromosomes and small pieces of DNA called copy number variants (CNVs). It works by comparing …